DRUG MANAGEMENT SOFTWARE FOR NCI CLINICAL TRIALS

用于 NCI 临床试验的药物管理软件

• 批准号: 6071505
• 负责人: STEPHEN W BURKE
• 金额: $ 37.5万
• 依托单位: DDOTS, INC.
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-06-05 至 2001-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6071505
• 关键词: artificial intelligence; clinical trials; computer assisted patient care; computer program /software; computer simulation; computer system design /evaluation; drug screening /evaluation; informatics

DDOTS was awarded a Phase I SBIR contract to create an algorithmic computer model which inventories and tracks all investigational drugs used in NCI-sponsored clinical trials. DDOTS met all of the requirements of the project with the development of a stand-alone system for pharmacy use entitled "Investigational Drug Environmental Accountability" (IDEA). At the request of the NCI's CTEP informatics workgroup, the project was extended for a period of six months in order to allow DDOTS to create and align the IDEA drug accountability file submission format for inclusion in the Drug Authorization and Review Tracking System (DARTS) being developed for NCI's Pharmacy Management Branch. Having successfully accomplished the above, the primary specific aim of this Phase II proposal is the actual production of the IDEA software system. The IDEA software program will be installed and operationalized at two beta test sites: the Ann Arbor Regional CCOP in Ann Arbor, Ml and the Carle Cancer Center in Urbana, IL. There is no investigational drug management and auditing software program presently available in either the commercial market or from health care organizations. The IDEA software provides a state-of-the-art technologic tool which serves to meet both the needs of cancer research sites and the NCI for improved efficiency, reliability, and cost-effectiveness in the overall investigational drug management and inventory process. PROPOSED COMMERCIAL APPLICATIONS: Although the IDEA software is being developed for NCI-sponsored research programs, broad applicability exists for its use by all organizations conducting drug research, i.e., comprehensive cancer programs, university hospitals, and pharmaceutical companies.

DDOT被授予I期SBIR合同，以创建算法计算机模型，该算法库存并跟踪NCI赞助的临床试验中使用的所有研究药物。 DDOTS通过开发独立的药房使用系统，标题为“研究药物环境问责制”（IDEA），DDOTS满足了该项目的所有要求。应NCI的CTEP信息组工作组的要求，该项目延长了六个月，以便DDOTS允许DDOTS创建和对齐该想法的药物责任文件提交格式，以包含在药物授权和审查跟踪系统（DARTS）中，该系统正在为NCI的药房管理部门开发。成功完成上述过程后，该II阶段提案的主要特定目的是实际生产Idea软件系统。 IDEA软件程序将在两个Beta测试网站上安装和运营：ML的Ann Arbor的Ann Arbor区域CCOP和伊利诺伊州Urbana的Carle Cancer Center。目前，商业市场或医疗保健组织都没有可用的研究药物管理和审核软件计划。该想法软件提供了一种最先进的技术工具，可满足癌症研究站点的需求和NCI的需求，以提高整体研究药物管理和库存过程中的效率，可靠性和成本效益。拟议的商业应用：尽管为NCI赞助的研究计划开发了IDEA软件，但对于所有进行药物研究的组织，即综合癌症计划，大学医院和制药公司的使用，都有广泛的适用性。